Barclays PLC 10x Genomics, Inc. Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Barclays PLC holds 785,830 shares of TXG stock, worth $7.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
785,830
Previous 790,957
0.65%
Holding current value
$7.43 Million
Previous $11.4 Million
39.6%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TXG
# of Institutions
304Shares Held
109MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.8MShares$121 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$105 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL7.1MShares$67.1 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$60.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.38MShares$50.8 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $898M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...